Skip to main content

Dr. Jorge Agi, MD

Ophthalmology (Ophthalmology Physician)

  • Medicare participating

At a glance

Years since graduation
14
In the NPI registry since
2023
Medicare patients seen, 2024
256

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2023Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Ophthalmology Physician primary
    FL license MFC1884
  • Ophthalmic Plastic and Reconstructive Surgery Physician
    FL license 1884

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Ophthalmology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
256
Services billed
2,145
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 10-19 minutes8870
Established patient office or other outpatient visit, 20-29 minutes6453
Established patient office or other outpatient visit, 30-39 minutes2625
New patient office or other outpatient visit, 30-44 minutes2424
Exam of visual field with intermediate testing2323
New patient office or other outpatient visit, 15-29 minutes2121
Photography of content of eyes1311
Photography of the retina1211
Insertion of probe into nasal tear duct1111

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 3 companies reported 9 payments worth $3,901 in total to this clinician.

By type
Honoraria$2,000
Travel and Lodging$1,665
Food and Beverage$236

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 16, 2025Immunocore Limited
Oct 16, 2025
Honoraria
KIMMTRAK · Oncology
$2,000
Sep 29, 2025Immunocore Limited
Sep 29, 2025
Travel and Lodging
KIMMTRAK · Oncology · travel to Donia Beach, FL · in-kind
$1,585
Sep 26, 2025Immunocore Limited
Sep 26, 2025
Travel and Lodging
KIMMTRAK · Oncology · travel to Donia Beach, FL · in-kind
$80.00

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Florida →

Industry-funded research

Named as a principal investigator on 3 industry-funded studies in 2025, from 1 companies. The companies reported $104,090 in research payments for these studies, mostly to the institutions running them.

  • A Phase 3, Randomized, Double-masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Durability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC ad…
    Argenx US, Inc.
  • A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Imm…
    Argenx US, Inc.
  • A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Acti…
    Argenx US, Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Ophthalmology clinicians in Tampa

Sources

NPI registry (CMS NPPES, November 2026; record last updated May 18, 2023), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1912602541. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.